The results showed that the positive rate of EBV-IgA antibody was relatively high in high-incidence area of NPC, while there was no significant differences in the antibody positive rates between medium-incidence areas and low-incidence areas of NPC. The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.